Kelly Bolton, MD, PhD

Bone Marrow Transplant Specialist, Medical Oncologist

Kelly Bolton

Appointment Options

Whether you’re seeking a new patient appointment or exploring treatment options and looking for a second opinion, our Siteman care coordinators are ready to assist you.

My Locations

Gary C. Werths Building at Siteman Cancer Center

Gary C. Werths Building at Siteman Cancer Center

On WashU Medicine Campus
4500 Forest Park Avenue, Saint Louis, MO 63108

Expertise & Training

Video thumbnail for Dr. Kelly Bolton, MD, PhD

Watch video on YouTube

Dr. Kelly Bolton, MD, PhD

5 mins

Dr. Kelly Bolton, MD, PhD Assistant Professor of Medicine, Division of Oncology Section of Bone Marrow Transplantation & Leukemia, Washington University School of Medicine at Siteman Cancer Center

Clinical Expertise

  • Leukemia, Genetic Counseling

Primary Academic Title

Associate Professor of Medicine, Division of Oncology, Section of Bone Marrow Transplantation & Leukemia, WashU Medicine

Board Certification

  • 2015: American Board of Medicine
  • 2018: American Board of Oncology

Training

  • 2015 - 2018: Fellow, Medical Oncology/Internal Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Education

  • 2011: PhD, Public Health and Primary Care, University of Cambridge, United Kingdom
  • 2013: MD, University of California, Los Angeles, CA

Research & Selected Publications

Research Interest

The interplay between inherited genetic variation, environmental factors and acquired mutations in shaping earliest carcinogenesis and cancer

Research Publications

Germline alterations in patients with lung cancer
Authors:

Govindan R, Navo K, Huang M, one or more additional authors omitted Bolton K, Cao Y

Journal & Year:

Ann Oncol | 2026

Clonal hematopoiesis and its progression to myeloid neoplasms: insights into risk, biology, and therapeutic strategies
Authors:

Beeler SJ, Walter MJ, Bolton KL

Journal & Year:

Haematologica | 2026

Clonal Hematopoiesis and Its Cardiovascular Implications: A Scientific Statement From the American Heart Association
Authors:

Rhee JW, Bolton KL, Gupta D, one or more additional authors omitted Natarajan P

Journal & Year:

Circulation | 2026

CDK4/6 inhibition mitigates chemotherapy-induced expansion of TP53-mutant clonal hematopoiesis
Authors:

Chan ICC, Zhang P, Pan X, one or more additional authors omitted Bolton KL

Journal & Year:

Nat Genet | 2026

Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenias of Undetermined Significance: 2026 Update on Clinical Associations and Management Recommendations
Authors:

Mangaonkar AA, Bolton KL, Patnaik MM

Journal & Year:

Am J Hematol | 2026

Clonal hematopoiesis detection by simultaneous assessment of peripheral blood mononuclear cells, blood plasma, and saliva
Authors:

Stewart CM, Parpart-Li S, White JR, one or more additional authors omitted Bolton KL, one or more additional authors omitted Diaz LA

Journal & Year:

J Clin Invest | 2025

Germline genetic variation impacts clonal hematopoiesis landscape and progression to malignancy
Authors:

Liu J, Tran D, Xue L, one or more additional authors omitted Bolton KL

Journal & Year:

Nat Genet | 2025

Integration of Germline and Somatic Variation Improves Chronic Lymphocytic Leukemia Risk Stratification
Authors:

Hubbard AK, Brown DW, Liu J, one or more additional authors omitted Bolton KL, Machiela MJ

Journal & Year:

Cancer Res | 2025